| 注册
首页|期刊导航|中国药理学通报|表观遗传学药物的研究进展

表观遗传学药物的研究进展

张玲 盛树力 秦川

中国药理学通报2013,Vol.29Issue(3):297-303,7.
中国药理学通报2013,Vol.29Issue(3):297-303,7.DOI:10.3969/j.issn.1001-1978.2013.03.001

表观遗传学药物的研究进展

Research progress in the epigenetic drug

张玲 1盛树力 1秦川1

作者信息

  • 折叠

摘要

Abstract

During the last decade, expanding studies on the proteins involved in DNA methylation and the post-translational modification of histone made it possible to develop epigenetic drugs. This review summarizes these potential epigenetic drugs which target the key proteins, like DNA methyltransferases, ly-sine demethylases, protein methyltransferases, histone deacety-lases, histone acetyltransferases, bromodomain-containing proteins, and proteins that bind to methylated histones.

关键词

表观遗传学/DNA甲基化/DNA甲基转移酶/组蛋白修饰/组蛋白乙酰化/组蛋白去乙酰化酶/组蛋白甲基化

Key words

epigenetics/ DNA methylation/ DNA methyltransferases ( DNMTs )/ histone modification/ histone acetylation/ histone deacetylases ( HDACs )/ histone methylation

分类

医药卫生

引用本文复制引用

张玲,盛树力,秦川..表观遗传学药物的研究进展[J].中国药理学通报,2013,29(3):297-303,7.

基金项目

国家科技重大专项(No 2009ZX09501) (No 2009ZX09501)

北京协和医学院博士创新基金(No 2010-1001-001) (No 2010-1001-001)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文